Currently out of the existing stock ratings of Dewey Steadman, 40 are a BUY (68.97%), 18 are a HOLD (31.03%).

Dewey Steadman

Work Performance Price Targets & Ratings Chart

Analyst Dewey Steadman, carries an average stock price target met ratio of 48.73% that have a potential upside of 19.68% achieved within 224 days. Previously, Dewey Steadman worked at CANACCORD.

Dewey Steadman’s has documented 113 price targets and ratings displayed on 10 stocks. The coverage was on the Healthcare sector.

Most recent stock forecast was given on AERI, Aerie Pharmaceuticals at 10-Jun-2019.

Wall Street Analyst Dewey Steadman

Analyst best performing recommendations are on INSM (INSMED).
The best stock recommendation documented was for INSM (INSMED) at 1/2/2019. The price target of $20 was fulfilled within 5 days with a profit of $6.03 (43.16%) receiving and performance score of 86.33.

Average potential price target upside

AERI Aerie Pharmaceuticals ANIP ANI Pharmaceuticals ENDP Endo International PLC MNK Mallinckrodt plc PCRX Pacira Pharmaceuticals PRGO Perrigo Company PLC PRTK Paratek Pharmaceuticals INSM Insmed LPCN Lipocine SVRA Savara

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Hold

$13

3 years 1 months 11 days ago
(28-Aug-2022)

1/5 (20%)

$4.7 (56.63%)

176

Hold

3 years 1 months 16 days ago
(23-Aug-2022)

0/1 (0%)

$6.53 (25.64%)

Hold

$20

3 years 1 months 16 days ago
(23-Aug-2022)

0/4 (0%)

$14.21 (245.42%)

Buy

$15.25

$27

3 years 1 months 17 days ago
(22-Aug-2022)

7/11 (63.64%)

$0.09 (0.59%)

149

Hold

$14

3 years 1 months 17 days ago
(22-Aug-2022)

6/14 (42.86%)

$6.36 (83.25%)

228

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What Year was the first public recommendation made by Dewey Steadman?

On 2016

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?